{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T02:28:20Z","timestamp":1789352900839,"version":"build-2803163510"},"reference-count":28,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2012,7,5]],"date-time":"2012-07-05T00:00:00Z","timestamp":1341446400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0040285","type":"journal-article","created":{"date-parts":[[2012,7,6]],"date-time":"2012-07-06T01:14:31Z","timestamp":1341537271000},"page":"e40285","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":25,"title":["Common Protein Biomarkers Assessed by Reverse Phase Protein Arrays Show Considerable Intratumoral Heterogeneity in Breast Cancer Tissues"],"prefix":"10.1371","volume":"7","author":[{"given":"Katharina","family":"Malinowsky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mithu","family":"Raychaudhuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa","family":"Buchner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Thulke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Wolff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heinz","family":"H\u00f6fler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl-Friedrich","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie","family":"Avril","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2012,7,5]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/bcr777","article-title":"Prognostic molecular markers in early breast cancer.","volume":"6","author":"FJ Esteva","year":"2004","journal-title":"Breast Cancer Res"},{"key":"ref2","first-page":"289","article-title":"HER2 breast cancer therapies: a review.","volume":"3","author":"CG Murphy","year":"2009","journal-title":"Biologics"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1186\/bcr309","article-title":"The E-cadherin\/catenin complex: an important gatekeeper in breast cancer tumorigenesis and malignant progression.","volume":"3","author":"G Berx","year":"2001","journal-title":"Breast Cancer Res"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1093\/jnci\/94.2.116","article-title":"Pooled analysis of prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in 8377 breast cancer patients.","volume":"94","author":"MP Look","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1159\/000151737","article-title":"Assessment of Urokinase-Type Plasminogen Activator and Its Inhibitor PAI-1 in Breast Cancer Tissue: Historical Aspects and Future Prospects.","volume":"3","author":"M Schmitt","year":"2008","journal-title":"Breast Care (Basel)"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/path.2791","article-title":"Signalling networks associated with urokinase-type plasminogen activator (uPA) and its inhibitor PAI-1 in breast cancer tissues: new insights from protein microarray analysis.","volume":"223","author":"C Wolff","year":"2011","journal-title":"J Pathol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1002\/pmic.200300598","article-title":"Signal pathway profiling of prostate cancer using reverse phase protein arrays.","volume":"3","author":"RL Grubb","year":"2003","journal-title":"Proteomics"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1038\/sj.onc.1204265","article-title":"Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front.","volume":"20","author":"CP Paweletz","year":"2001","journal-title":"Oncogene"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1002\/pmic.200300592","article-title":"Protein microarrays: molecular profiling technologies for clinical specimens.","volume":"3","author":"V Espina","year":"2003","journal-title":"Proteomics"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S1535-6108(03)00086-2","article-title":"Protein microarrays: meeting analytical challenges for clinical applications.","volume":"3","author":"LA Liotta","year":"2003","journal-title":"Cancer Cell"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/ncponc0485","article-title":"Technology insight: pharmacoproteomics for cancer\u2013promises of patient-tailored medicine using protein microarrays.","volume":"3","year":"2006","journal-title":"Nat Clin Pract Oncol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/978-1-61779-286-1_8","article-title":"Use of formalin-fixed and paraffin-embedded tissues for diagnosis and therapy in routine clinical settings.","volume":"785","author":"D Berg","year":"2011","journal-title":"Methods Mol Biol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/978-1-61779-286-1_9","article-title":"Producing reverse phase protein microarrays from formalin-fixed tissues.","volume":"785","author":"C Wolff","year":"2011","journal-title":"Methods Mol Biol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"4301","DOI":"10.1038\/sj.onc.1202790","article-title":"Tumour-associated E-cadherin mutations alter cellular morphology, decrease cellular adhesion and increase cellular motility.","volume":"18","author":"G Handschuh","year":"1999","journal-title":"Oncogene"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1007\/BF01774016","article-title":"Accurate assessment of precision errors: how to measure the reproducibility of bone densitometry techniques.","volume":"5","author":"CC Gluer","year":"1995","journal-title":"Osteoporos Int"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses.","volume":"327","author":"JP Higgins","year":"2003","journal-title":"BMJ"},{"key":"ref17","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmoldx.2012.01.016","article-title":"Intratumoral heterogeneity of microRNA expression in breast cancer.","author":"M Raychaudhuri","year":"2012"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/PAI.0b013e3181dddb20","article-title":"Intratumoral heterogeneity of immunohistochemical marker expression in breast carcinoma: a tissue microarray-based study.","volume":"18","author":"A Nassar","year":"2010","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1309\/AJCP09VUTZWZXBMJ","article-title":"Genotypic intratumoral heterogeneity in breast carcinoma with HER2\/neu amplification: evaluation according to ASCO\/CAP criteria.","volume":"131","author":"M Brunelli","year":"2009","journal-title":"Am J Clin Pathol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1177\/1066896906293055","article-title":"Intratumoral heterogeneity of her-2\/neu in invasive mammary carcinomas using fluorescence in-situ hybridization and tissue microarray.","volume":"14","author":"SJ Shin","year":"2006","journal-title":"Int J Surg Pathol"},{"key":"ref21","first-page":"1493","article-title":"Genetic divergence in the clonal evolution of breast cancer.","volume":"56","author":"H Fujii","year":"1996","journal-title":"Cancer Res"},{"key":"ref22","first-page":"3884","article-title":"Genome-wide search for loss of heterozygosity using laser capture microdissected tissue of breast carcinoma: an implication for mutator phenotype and breast cancer pathogenesis.","volume":"60","author":"CY Shen","year":"2000","journal-title":"Cancer Res"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1097\/01.LAB.0000032371.16521.40","article-title":"Marked intratumoral heterogeneity of c-myc and cyclinD1 but not of c-erbB2 amplification in breast cancer.","volume":"82","author":"S Glockner","year":"2002","journal-title":"Lab Invest"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/ijc.2910580108","article-title":"Intratumoral heterogeneity for amplified genes in human breast carcinoma.","volume":"58","author":"U Lonn","year":"1994","journal-title":"Int J Cancer"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1113205","article-title":"Intratumor heterogeneity and branched evolution revealed by multiregion sequencing.","volume":"366","author":"M Gerlinger","year":"2012","journal-title":"N Engl J Med"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/path.2107","article-title":"Quantitative protein analysis from formalin-fixed tissues: implications for translational clinical research and nanoscale molecular diagnosis.","volume":"211","author":"KF Becker","year":"2007","journal-title":"J Pathol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/PAI.0b013e3182054f9f","article-title":"Protein microarray-based comparison of HER2, estrogen receptor, and progesterone receptor status in core biopsies and surgical specimens from FFPE breast cancer tissues.","volume":"19","author":"D Berg","year":"2011","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s12014-010-9055-y","article-title":"A Technical Assessment of the Utility of Reverse Phase Protein Arrays for the Study of the Functional Proteome in Non-microdissected Human Breast Cancers.","volume":"6","author":"BT Hennessy","year":"2010","journal-title":"Clin Proteomics"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0040285","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,20]],"date-time":"2022-01-20T09:40:43Z","timestamp":1642671643000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0040285"}},"subtitle":[],"editor":[{"given":"Syed A.","family":"Aziz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2012,7,5]]},"references-count":28,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2012,7,5]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0040285","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,7,5]]}}}